Earnings Summary

Vertex Pharmaceuticals Incorporated’s revenue jumped 11.61% since last year same period to $2771.9Mn in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 5.21% jump in its revenue since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit jumped 0.98% since last year same period to $1045.4Mn in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 129.09% jump in its net profits since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit margin fell -9.53% since last year same period to 37.71% in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 127.65% jump in its net profit margins since last 3-months.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 4.14 - a 40.82% jump from last quarter’s estimates.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 4.14.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) jumped 7.35% since last year same period to 4.38 in the Q3 2024. This indicates that the Vertex Pharmaceuticals Incorporated has generated 7.35% annual rate of jump in its earning per share (EPS) in the last 4 quarters.